Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs. [PDF]
Protection against viral challenge with canine oral papillomavirus (COPV) was achieved by immunisation via particle-mediated DNA delivery (PMDD) of a plasmid encoding the COPV L1 gene to cutaneous and oral mucosal sites in beagle dogs.
Walcott, S. +7 more
core
We present the burden of human papillomavirus (HPV)-related cancers (cancers of the cervix, anogenital region, oral cavity and pharynx) in terms of incidence and mortality, for the countries of the Latin America and Caribbean region. The region is a high-
Piñeros, Marion +11 more
core +1 more source
Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
Cell lines transformed by bovine papillomavirus type 1 DNA were established from transfected primary fibroblast cultures of C57BL/6 mice. Southern blot analysis revealed that most of the viral DNA in the cells was in episomal oligomeric form. These cell lines were tested for tumorigenicity in nude mice in comparison to properties associated with ...
R, Mäntyjärvi +5 more
openaire +1 more source
Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley +1 more source
Strategies for studying mouse and human immune responses to human papillomavirus type 16.
Cytotoxic T lymphocytes (CTL) are an important protective mechanism in viral infection and can be effective against tumours. We have investigated the tumour-associated E6 and E7 genes of human papillomavirus type 16 as CTL targets. In H-2b mice we have defined epitopes in E6 and E7 which can readily generate CTL in vivo and we have shown that HLA-A2.1 ...
Beverley, P +9 more
openaire +2 more sources
Papillomaviruses, group-specific papillomavirus antigens, or extrachromosomal papillomavirus DNA were detected in cutaneous, mucocutaneous, and pulmonary tumors affecting a colony of European harvest mice (Micromys minutus).
O\u27Banion, M K +4 more
core
1. Describe the pathophysiology of human papillomavirus (HPV) infection 2. Analyze available literature regarding efficacy of HPV vaccines in females and males 3.
I. Human Papillomavirus (hpv +1 more
core
A novel HPV mRNA vaccine candidate: immunogenicity and definition of immune correlates of protection. [PDF]
Hwang H, An T, Seo EH, Park PG, Hong KJ.
europepmc +1 more source
Endolysosomal routing combined with immune stimulation enhances anti-tumor efficacy of an HPV16 mRNA therapeutic vaccine. [PDF]
Song W +10 more
europepmc +1 more source
Establishment of an immortalized porcine erythroid progenitor cell line using species-adapted papillomavirus oncogenes. [PDF]
Tran TM +8 more
europepmc +1 more source

